Enhancing Specificity Without Sacrificing Sensitivity: Potential Benefits of Using Microvolt T-Wave Alternans Testing to Risk Stratify the MADIT-II Population

By Cohen R.J.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 438-442

Springer Publishing Company

Access to resources Recommend Favorite

Using the MADIT II Criteria for Implantable Cardioverter Defibrillators—What is the Role of the Food and Drug Administration Approval?

By Barold H.S.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 443-446

Springer Publishing Company

Access to resources Recommend Favorite

Characterization and Hemodynamic Implications of Renal Vascular Angiotensin II Receptors in SHR

By Haddad G.   Garcia R.  

Journal of Molecular and Cellular Cardiology, Vol. 28, Iss. 2, 1996-02 ,pp. : 351-361

Academic Press

Access to resources Recommend Favorite

Angiotensin II, Cell Proliferation and Angiogenesis Regulator: Biologic and Therapeutic Implications in Cancer

By  

Current Vascular Pharmacology, Vol. 2, Iss. 4, 2004-10 ,pp. : 385-399

Bentham Science Publishers

Access to resources Recommend Favorite

Second Vasovagal Pacemaker Study (VPS II): Rationale, Design, Results, and Implications for Practice and Future Clinical Trials

By Sheldon R.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 411-415

Springer Publishing Company

Access to resources Recommend Favorite